Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: LJL Biosystems, Inc (LJLB)

No earlier versions found for this Subject.

Return to LJL Biosystems, Inc (LJLB)

"LJL Biosystems, Inc. designs, produces and sells to pharmaceutical and biotechnology firms products and services that accelerate and enhance the drug discovery process. For the nine months ended 9/30/99, net sales totalled $6 million, up from $2.8 million. Net loss applicable to Common rose 6% to $6.9 million. Revenues reflect higher unit sales volume of Analyst-TM-HT instrument and some OEM revenue. Higher loss reflects the addition of sales and marketing personnel."

(Pasted from Yahoo Finance profile)

I'm amazed that there has been no thread for this up to now. It came up in a screen for stocks breaking out . . .